Study to Evaluate Safety and Efficacy of Revanesse® Ultra + vs Revanesse® Ultra for Correction of NLF
Clinical trial NCT02991040 · COMPLETED
Trial details
- NCT number
- NCT02991040
- Sponsor
- Prollenium Medical Technologies Inc.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2017-08-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.